End Brain Cancer Initiative adds Dr. Jessica Schulte to medical advisory board

The End Brain Cancer Initiative said June 11, 2026, that neuro-oncologist Dr. Jessica D. Schulte has joined its Medical Advisory Board. The addition expands the group’s expertise in adolescent and young adult brain cancer care, along with primary and metastatic brain tumors. Why it matters: - Dr. Jessica D. Schulte brings specialty expertise in adolescent and young adult neuro-oncology to the End Brain Cancer Initiative’s Medical Advisory Board. - The appointment adds experience in primary and metastatic brain tumors, neurofibromatosis and schwannomatosis. - EBCI said the addition helps the organization better serve brain cancer and brain tumor patients seeking access to specialists, advanced diagnostics, treatments and clinical trials. What happened: - The End Brain Cancer Initiative announced June 11, 2026, that Dr. Jessica D. Schulte joined its Medical Advisory Board. - EBCI is a 501(c)3 non-profit patient advocacy organization based in Seattle. - Dr. Schulte is a neuro-oncologist at NYU Langone Brain & Spine Tumor Center. - Dellann Elliott Mydland, EBCI president and CEO, welcomed Dr. Schulte to the board. The details: - Dr. Schulte treats patients with primary and metastatic brain tumors, neurofibromatosis and schwannomatosis. - Her clinical focus covers late adolescence through adulthood. - Dr. Schulte said she wants to improve access to novel, targeted treatments for adolescent and young adult patients. - Dr. Schulte also said she will push for better quality of life during and after treatment. - Mydland said Dr. Schulte’s expertise fills an area that was not previously represented on the Medical Advisory Board. - EBCI said the organization has supported the brain tumor community for more than 20 years. Between the lines: - The appointment signals EBCI is broadening its advisory bench around a patient group that often faces different treatment and quality-of-life needs than older adults. - The focus on access and quality of life suggests the organization is aiming to pair clinical expertise with advocacy for practical care improvements. - EBCI’s emphasis on adolescent and young adult patients reflects a gap it sees in specialty coverage and patient support. What’s next: - EBCI said it expects to work closely with Dr. Schulte to better serve brain cancer communities. - The organization continues to seek support for its programs and services, including a suggested $50 donation through its donation page . - EBCI directs readers to EndBrainCancer.org for more information. The bottom line: - EBCI is adding a specialist whose background aligns with its push for broader access, more targeted treatment options and stronger support for younger brain cancer patients.